Park, J. C., Jung, H. A., Kim, Y., Merkin, R. D., Roberts, T. J., Patel, M. J., Park, B., Kim, J., Park, S., Sun, J., Lee, S., Ahn, J. S., Ahn, M., Wirth, L. J. (2026). Outcomes of PD-(L)1 inhibitor continuation or rechallenge after first-line progression in recurrent or metastatic head and neck squamous cell carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.6059